7）Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, et al. Advanced heart failure epidemiology and outcomes: A population-based study. JACC Heart Fail 2021; 9: 722-32. 8）Greenberg B, Fang J, Mehra M, Stevenson LW. Advanced heart failure: Trans-Atlantic perspectives on the Heart Failure Association of the European Society of Cardiology position statement. Eur J Heart Fail 2018; 20: 1536-9. 9）Gerhardt LMS, Kordsmeyer M, Sehner S, Güder G, Störk S, Edelmann F, et al. Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages. Clin Res Cardiol 2023; 112: 868-79.10）Adams KF Jr, Patterson JH, Oren RM, Mehra MR, O’Conner CM, Piña IL, et al. Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Am Heart J 2009; 157: 926-32.11）Suenaga T, Fujino T, Hashimoto T, Ishikawa Y, Shinohara K, Matsushima S, et al. Hemoglobin level can predict heart failure hospitalization in patients with advanced heart failure awaiting heart transplantation without inotropes or mechanical circulatory support. Int Heart J 2024; 65: 667-75.文 献56 1）Tang YD, Katz SD. The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes. Heart Fail Rev 2008; 13: 387-92. 2）Yamauchi T, Sakata Y, Takada T, Nochioka K, Miura M, Tadaki S, et al. Prognostic impact of anemia in patients with chronic heart failure- With special reference to clinical background: Report from the CHART-2 study. Circ J 2015; 79: 1984-93. 3）Anand IS, Gupta P. Anemia and iron deficiency in heart failure: Current concepts and emerging therapies. Circulation 2018; 138: 80-98. 4）Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure- The anemia in chronic heart failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113: 2713-23. 5）von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure: An overview. JACC Heart Fail 2019; 7: 36-46. 6）Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Entl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 2015; 36: 657-68.
元のページ ../index.html#70